Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.46
-0.41 (-2.58%)
At close: Apr 21, 2026, 4:00 PM EDT
15.46
0.00 (0.00%)
After-hours: Apr 21, 2026, 4:10 PM EDT
Janux Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$48.73
Upside
+215.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy → Sell Downgrades $29 → $14 | Buy → Sell | Downgrades | $29 → $14 | -9.44% | Apr 20, 2026 |
| UBS | UBS | Strong Buy → Hold Downgrades $57 → $15 | Strong Buy → Hold | Downgrades | $57 → $15 | -2.98% | Apr 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $150 → $100 | Buy | Maintains | $150 → $100 | +546.83% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $68 | Strong Buy | Maintains | $72 → $68 | +339.84% | Feb 27, 2026 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $32 → $12 | Strong Buy → Hold | Downgrades | $32 → $12 | -22.38% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +94.05% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +87.58% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +145.80% | Dec 2, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +106.99% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $58 → $49 | Strong Buy | Maintains | $58 → $49 | +216.95% | Dec 2, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $150 | Buy | Maintains | $200 → $150 | +870.25% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $45 | Strong Buy | Maintains | $70 → $45 | +191.07% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +352.78% | Nov 25, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| Barclays | Barclays | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +210.48% | Nov 7, 2025 |
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +204.01% | Sep 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.